The Lancet

By Dave Muoio July 12, 2018
An investigation published yesterday in The Lancet Psychiatry found that automated cognitive intervention delivered via sessions with a consumer-grade virtual reality headset effectively reduced individuals’ fear of heights, and was generally well received by those participating in the study. The results, researchers wrote, suggest that similar automated VR treatments could potentially be viable...
By Heather Mack December 5, 2016
For people who have had an amputation, the phantom pain they experience in the missing limbs is as real as any other pain. However, treating pain at a source that is no longer there has long baffled scientists, and many existing therapies, including the use of implantable nerve stimulators or medications, offer no relief for many phantom pain sufferers. But a new study shows augmented reality may...
By Jonah Comstock August 18, 2014
Remote monitoring of patients with implantable cardiac devices reduced the mortality rate for cardiac patients by 50 percent and improved their clinical status by nearly 10 percent in a randomized control trial recently published in The Lancet. The trial was sponsored by medical device company Biotronik. The trial was conducted at 36 different clinics and hospitals in Europe, Australia, and...
By Neil Versel September 10, 2012
Agile Health, maker of an SMS-based smoking cessation program for employers and other group purchasers of health insurance, has raised $2 million in private equity to finance development of a similar offering for diabetes management, according to regulatory filings and published reports. Nashville, Tenn.-based Agile Health disclosed in a filing with the Securities and Exchange Commission last...